TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

NCT00789997 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

COPD Exacerbation

Interventions

DRUG: Prednisone
DRUG: Etanercept
DRUG: levofloxacin

Sponsor

Ottawa Hospital Research Institute